Dignitana Initiates Action with American Medical Association to Add CPT® Codes for Insurance Coverage of FDA-Cleared Scalp Cooling Medical Devices
Maker of the World’s First FDA-Cleared Therapeutic for Reducing Chemotherapy-Induced Hair Loss Takes the Lead in Making Treatments More Widely Accessible for Women and Men EverywhereLund, Sweden – 16 March 2018 – Dignitana AB , world leader in clinically superior scalp cooling technology, has begun the process of obtaining a Current Procedural Terminology (CPT®) Code for FDA-cleared scalp cooling systems used in the prevention of chemotherapy-induced hair loss – a move that is critical to wide adoption of the practice in cancer centers across the U.S. and that